Cutting edge: Rac GTPases sensitize activated T Cells to die via Fas

被引:33
作者
Ramaswamy, Madhu
Dumont, Celine
Cruz, Anthony C.
Muppidi, Jagan R.
Gomez, Timothy S.
Billadeau, Daniel D.
Tybulewicz, Victor L. J.
Siegel, Richard M.
机构
[1] NIAMSD, Immunoregulat Unit, Autoimmun Branch, Natl Inst Hlth, Bethesda, MD 20892 USA
[2] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England
[3] Mayo Clin, Dept Oncol Res, Rochester, MN 55905 USA
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.179.10.6384
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inactivated CD4(+) T cells, TCR restimulation triggers apoptosis that depends on interactions between the death receptor Fas and its ligand, FasL. This process, termed restimulation-induced cell death (RICD), is a mechanism of peripheral immune tolerance. TCR signaling sensitizes activated T cells to Fas-mediated apoptosis, but what pathways mediate this process are not known. In this study we identify the Rho GTTases Rac1 and Rac2 as essential components in restimulation-induced cell death. RNA interference-mediated knockdown of Rac GTPases greatly reduced Fas-dependent, TCR-induced apoptosis. The ability of Rac1 to sensitize T cells to Tas-induced apoptosis correlated with Rac-mediated cytoskeletal reorganization, dephosphorylation of the ERM (ezrin/radixin/moesin) family of cytoskeletal linker proteins, and the translocation of Fas to lipid raft microdomains. In primary activated CD4+ T cells, Rac1 and Rac2 were independently required for maximal TCR-induced apoptosis. Activating Rac signaling may be a novel way to sensitize chronically stimulated lymphocytes to Fas induced apoptosis, an important goal in the treatment of autoimmune diseases.
引用
收藏
页码:6384 / 6388
页数:5
相关论文
共 20 条
  • [1] Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line
    Cao, YJ
    Janssen, EM
    Duncan, AW
    Altman, A
    Billadeau, DD
    Abraham, RT
    [J]. EMBO JOURNAL, 2002, 21 (18) : 4809 - 4819
  • [2] CD44-deficient mice exhibit enhanced hepatitis after concanavalin a injection: Evidence for involvement of CD44 in activation-induced cell death
    Chen, DW
    McKallip, RJ
    Zeytun, A
    Do, YK
    Lombard, C
    Robertson, JL
    Mak, TW
    Nagarkatti, PS
    Nagarkatti, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 5889 - 5897
  • [3] Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo
    Combadière, B
    Sousa, CR
    Trageser, C
    Zheng, LX
    Kim, CR
    Lenardo, MJ
    [J]. IMMUNITY, 1998, 9 (03) : 305 - 313
  • [4] ETTINGER R, 1995, J IMMUNOL, V154, P4302
  • [5] ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation
    Faure, S
    Salazar-Fontana, LI
    Semichon, M
    Tybulewicz, VLJ
    Bismuth, G
    Trautmann, A
    Germain, RN
    Delon, J
    [J]. NATURE IMMUNOLOGY, 2004, 5 (03) : 272 - 279
  • [6] DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
    FISHER, GH
    ROSENBERG, FJ
    STRAUS, SE
    DALE, JK
    MIDDELTON, LA
    LIN, AY
    STROBER, W
    LENARDO, MJ
    PUCK, JM
    [J]. CELL, 1995, 81 (06) : 935 - 946
  • [7] Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse
    Gomez, Timothy S.
    Kumar, Karan
    Mecleiros, Ricardo B.
    Shimizu, Yoji
    Leibson, Paul J.
    Billadeau, Daniel D.
    [J]. IMMUNITY, 2007, 26 (02) : 177 - 190
  • [8] Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse
    Gomez, TS
    Hamann, MJ
    McCarney, S
    Savoy, DN
    Lubking, CM
    Heldebrant, MP
    Labno, CM
    McKean, DJ
    McNiven, MA
    Burkhardt, JK
    Billadeau, DD
    [J]. NATURE IMMUNOLOGY, 2005, 6 (03) : 261 - 270
  • [9] Autoimmune lymphoproliferative syndrome with somatic Fas mutations
    Holzelova, E
    Vonarbourg, C
    Stolzenberg, MC
    Arkwright, PD
    Selz, F
    Prieur, AM
    Blanche, S
    Bartunkova, J
    Vilmer, E
    Fischer, A
    Le Deist, F
    Rieux-Laucat, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) : 1409 - 1418
  • [10] Hornung F, 1997, J IMMUNOL, V159, P3816